Literature DB >> 26617750

Knockdown of eIF3D inhibits breast cancer cell proliferation and invasion through suppressing the Wnt/β-catenin signaling pathway.

Yan Fan1, Yufei Guo1.   

Abstract

eIF3D (eukaryotic translation initiation factor 3 subunit D) is one member of the eIF3 family and plays a critical role in translation initiation. Previous studies showed that it was involved in the development and progression of several tumors. However, the role of eIF3D in breast cancer and the underlying mechanism is still unclear. Therefore, this study set out to investigate the role of eIF3D in breast cancer. Our results demonstrated that eIF3D is up-regulated in breast cancer cells. Knockdown of eIF3D inhibited breast cancer cell proliferation and invasion. In addition, knockdown of eIF3D inhibited the expression of β-catenin, cyclin D1 and c-Myc in breast cancer cells. Taken together, our findings show that siRNA-eIF3D inhibits breast cancer cell proliferation and invasion through suppressing the Wnt/β-catenin signaling pathway. Therefore, eIF3D may be a good molecular target for the prevention and treatment of breast cancer.

Entities:  

Keywords:  breast cancer; eIF3D (eukaryotic translation initiation factor 3 subunit D); invasion; proliferation

Mesh:

Substances:

Year:  2015        PMID: 26617750      PMCID: PMC4637565     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  27 in total

1.  Mapping the amplification of EIF3S3 in breast and prostate cancer.

Authors:  N N Nupponen; J Isola; T Visakorpi
Journal:  Genes Chromosomes Cancer       Date:  2000-06       Impact factor: 5.006

Review 2.  Epithelial-mesenchymal transitions in tumour progression.

Authors:  Jean Paul Thiery
Journal:  Nat Rev Cancer       Date:  2002-06       Impact factor: 60.716

Review 3.  Translational control of gene expression during hypoxia.

Authors:  Twan van den Beucken; Marianne Koritzinsky; Bradly G Wouters
Journal:  Cancer Biol Ther       Date:  2006-07-01       Impact factor: 4.742

Review 4.  eIF3: a versatile scaffold for translation initiation complexes.

Authors:  Alan G Hinnebusch
Journal:  Trends Biochem Sci       Date:  2006-08-22       Impact factor: 13.807

Review 5.  Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer.

Authors:  David J McConkey; Woonyoung Choi; Lauren Marquis; Frances Martin; Michael B Williams; Jay Shah; Robert Svatek; Aditi Das; Liana Adam; Ashish Kamat; Arlene Siefker-Radtke; Colin Dinney
Journal:  Cancer Metastasis Rev       Date:  2009-12       Impact factor: 9.264

6.  Functional interaction of beta-catenin with the transcription factor LEF-1.

Authors:  J Behrens; J P von Kries; M Kühl; L Bruhn; D Wedlich; R Grosschedl; W Birchmeier
Journal:  Nature       Date:  1996-08-15       Impact factor: 49.962

7.  Knockdown of EIF3D suppresses proliferation of human melanoma cells through G2/M phase arrest.

Authors:  Hui Li; Fusheng Zhou; Hongyan Wang; Da Lin; Gang Chen; Xianbo Zuo; Liangdan Sun; Xuejun Zhang; Sen Yang
Journal:  Biotechnol Appl Biochem       Date:  2015-01-12       Impact factor: 2.431

Review 8.  Wnt signaling and breast cancer.

Authors:  Louise R Howe; Anthony M C Brown
Journal:  Cancer Biol Ther       Date:  2004-01-14       Impact factor: 4.742

Review 9.  The mechanism of eukaryotic translation initiation and principles of its regulation.

Authors:  Richard J Jackson; Christopher U T Hellen; Tatyana V Pestova
Journal:  Nat Rev Mol Cell Biol       Date:  2010-02       Impact factor: 94.444

Review 10.  eIF-4E expression and its role in malignancies and metastases.

Authors:  Arrigo De Benedetti; Jeremy R Graff
Journal:  Oncogene       Date:  2004-04-19       Impact factor: 9.867

View more
  17 in total

1.  LINC01420 RNA structure and influence on cell physiology.

Authors:  Daria O Konina; Alexandra Yu Filatova; Mikhail Yu Skoblov
Journal:  BMC Genomics       Date:  2019-05-08       Impact factor: 3.969

2.  Knockdown of eukaryotic translation initiation factor 3 subunit B inhibits cell proliferation and migration and promotes apoptosis by downregulating WNT signaling pathway in acute myeloid leukemia.

Authors:  Yonghuai Feng; Liusong Wu
Journal:  Int J Clin Exp Pathol       Date:  2020-01-01

Review 3.  Translation initiation factors and their relevance in cancer.

Authors:  Columba de la Parra; Beth A Walters; Phillip Geter; Robert J Schneider
Journal:  Curr Opin Genet Dev       Date:  2017-11-16       Impact factor: 5.578

4.  High expression of eIF3d is associated with poor prognosis in patients with gastric cancer.

Authors:  Jiaqi He; Xuefei Wang; Jianhua Cai; Wei Wang; Xinyu Qin
Journal:  Cancer Manag Res       Date:  2017-10-25       Impact factor: 3.989

5.  EIF3D promotes gallbladder cancer development by stabilizing GRK2 kinase and activating PI3K-AKT signaling pathway.

Authors:  Fei Zhang; Shanshan Xiang; Yang Cao; Maolan Li; Qiang Ma; Haibin Liang; Huaifeng Li; Yuanyuan Ye; Yijian Zhang; Lin Jiang; Yunping Hu; Jian Zhou; Xuefeng Wang; Yong Zhang; Lei Nie; Xiao Liang; Wei Gong; Yingbin Liu
Journal:  Cell Death Dis       Date:  2017-06-08       Impact factor: 8.469

6.  Eukaryotic translation initiation factor 3 subunit D overexpression is associated with the occurrence and development of ovarian cancer.

Authors:  Yaying Lin; Rongrong Zhang; Ping Zhang
Journal:  FEBS Open Bio       Date:  2016-10-31       Impact factor: 2.693

7.  Reduced eIF3d accelerates HIV disease progression by attenuating CD8+ T cell function.

Authors:  Ying Pan; Zi-Ning Zhang; Lin-Bo Yin; Ya-Jing Fu; Yong-Jun Jiang; Hong Shang
Journal:  J Transl Med       Date:  2019-05-22       Impact factor: 5.531

8.  Roles of eIF3m in the tumorigenesis of triple negative breast cancer.

Authors:  Wei Han; Cong Zhang; Chun-Tao Shi; Xiao-Jiao Gao; Ming-Hui Zhou; Qi-Xiang Shao; Xiao-Jun Shen; Cheng-Jiang Wu; Fang Cao; Yong-Wei Hu; Jian-Liang Yuan; Hou-Zhong Ding; Qing-Hua Wang; Hao-Nan Wang
Journal:  Cancer Cell Int       Date:  2020-04-29       Impact factor: 5.722

9.  Proteomics analysis of bladder cancer invasion: Targeting EIF3D for therapeutic intervention.

Authors:  Agnieszka Latosinska; Marika Mokou; Manousos Makridakis; William Mullen; Jerome Zoidakis; Vasiliki Lygirou; Maria Frantzi; Ioannis Katafigiotis; Konstantinos Stravodimos; Marie C Hupe; Maciej Dobrzynski; Walter Kolch; Axel S Merseburger; Harald Mischak; Maria G Roubelakis; Antonia Vlahou
Journal:  Oncotarget       Date:  2017-04-20

Review 10.  Role of RONS and eIFs in Cancer Progression.

Authors:  Yasmeen Ahmed Salaheldin; Salma Sayed Mohamed Mahmoud; Ebenezeri Erasto Ngowi; Vivian Aku Gbordzor; Tao Li; Dong-Dong Wu; Xin-Ying Ji
Journal:  Oxid Med Cell Longev       Date:  2021-07-05       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.